Investing

Revvity : RVTY

RVTY

Stock Data

$117.71

$0.18 (0.15%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DIAGNOSTICS & RESEARCH

Revvity Inc, formerly known as PerkinElmer, is a global provider of health sciences solutions, technologies, and services. With a focus on Life Sciences and Diagnostics, the company offers a wide range of products including instruments, reagents, software, and services for genetic disorder detection and infectious disease testing. Its innovative technologies support genomic workflows in oncology, immunodiagnostics, and drug discovery. Serving a diverse clientele, from pharmaceutical companies to academic institutions, Revvity is a key player in advancing healthcare research and diagnostics. Founded in 1937, it is headquartered in Waltham, Massachusetts.

Latest Activity

RVTYRevvity

Q2 2026

Aug 4, 6:20am ET

EPS

$1.41

est $1.22+15.9%

Revenue

$730M

est $703M+3.8%

Diagnostics carried the quarter with 11% pro forma organic growth and margin widening to 30.4% from 25.2%, enough to offset a 3% organic decline in Life Sciences. Management raised full-year pro forma guidance to $2.83B-$2.86B in revenue and $5.30-$5.40 adjusted EPS, and is plowing part of $16 million in tariff refunds back into growth investments.

Loading…

ShareRead more

RVTYRevvity, Inc.

Reports Tue Aug 4Before open6:00 AM ETConfirmed

Aug 4, 5:00am ET

Revvity reports at 6:00 AM ET, before the bell, and it lands as one of the first clean reads on whether biotech R&D budgets are still tight. Anyone holding life sciences tools names gets an early demand signal hours before the open.

ShareRead more

All Revvity Articles

0 Articles

No articles found for Revvity.